Search research articles
Contact Us
Filters
Showing results (21-30 of 122) with videos related to
Page
of 13
Sort By:
Psychological Medicine
|
June 22, 2022
Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of <sup>18</sup>FDG-PET studies in schizophrenia
Leigh Townsend, Toby Pillinger, Pierluigi Selvaggi, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 23, 2024
Severe neutropenia unrelated to clozapine in patients receiving clozapine
David Taylor, Kalliopi Vallianatou, Shreyans Gandhi, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 28, 2020
Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study
Faith Borgan, Mattia Veronese, Tiago Reis Marques, et al.
Elife
|
November 13, 2019
The effects of psychosocial stress on dopaminergic function and the acute stress response
Michael Ap Bloomfield, Robert A McCutcheon, Matthew Kempton, et al.
Current Pharmaceutical Design
|
January 14, 2012
Economic impact of early detection and early intervention of psychosis
Lucia R Valmaggia, Philip K McGuire, Paolo Fusar-Poli, et al.
JAMA Network Open
|
January 16, 2019
Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis
Faith Borgan, Owen O'Daly, Karen Hoang, et al.
The Lancet. Psychiatry
|
January 23, 2025
Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study
Heidi Taipale, Antti Tanskanen, Oliver Howes, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 22, 2018
The effects of haloperidol on microglial morphology and translocator protein levels: An in vivo study in rats using an automated cell evaluation pipeline
Peter S Bloomfield, David Bonsall, Lisa Wells, et al.
Current Pharmaceutical Design
|
October 2, 2014
The role of white matter abnormalities in treatment-resistant depression: a systematic review
Gianluca Serafini, Maurizio Pompili, Stefan Borgwardt, et al.
Psychological Medicine
|
June 17, 2026
Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia
Ricardo Twumasi, Frederikke Hørdam Gronemann, Carsten Hjorthøj, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 122) with videos related to
Sort By:
Page
of 13
Psychological Medicine
|
June 22, 2022
Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of <sup>18</sup>FDG-PET studies in schizophrenia
Leigh Townsend, Toby Pillinger, Pierluigi Selvaggi, et al.
Journal of Psychopharmacology (Oxford, England)
|
July 23, 2024
Severe neutropenia unrelated to clozapine in patients receiving clozapine
David Taylor, Kalliopi Vallianatou, Shreyans Gandhi, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 28, 2020
Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study
Faith Borgan, Mattia Veronese, Tiago Reis Marques, et al.
Elife
|
November 13, 2019
The effects of psychosocial stress on dopaminergic function and the acute stress response
Michael Ap Bloomfield, Robert A McCutcheon, Matthew Kempton, et al.
Current Pharmaceutical Design
|
January 14, 2012
Economic impact of early detection and early intervention of psychosis
Lucia R Valmaggia, Philip K McGuire, Paolo Fusar-Poli, et al.
JAMA Network Open
|
January 16, 2019
Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis
Faith Borgan, Owen O'Daly, Karen Hoang, et al.
The Lancet. Psychiatry
|
January 23, 2025
Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study
Heidi Taipale, Antti Tanskanen, Oliver Howes, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 22, 2018
The effects of haloperidol on microglial morphology and translocator protein levels: An in vivo study in rats using an automated cell evaluation pipeline
Peter S Bloomfield, David Bonsall, Lisa Wells, et al.
Current Pharmaceutical Design
|
October 2, 2014
The role of white matter abnormalities in treatment-resistant depression: a systematic review
Gianluca Serafini, Maurizio Pompili, Stefan Borgwardt, et al.
Psychological Medicine
|
June 17, 2026
Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia
Ricardo Twumasi, Frederikke Hørdam Gronemann, Carsten Hjorthøj, et al.
Page
of 13